Evidence map›Paper›PMID 42360584›Full record

ArticleMolecular diversity2026

Total synthesis of the proposed menominin A and its stereoisomers: identification of a highly potent isomer (1a) against RM-1 prostate cancer cells.

Yu Jiang, Xin Li, Jiayi Li, Yuhan Xiao, Huiling Xu, Junqiu Zhang, Min-Jing Cheng, Junyang Liu, Jia-Lei Yan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu Jiang *School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, 529020, China.
Xin Li *Center for Bioactive Natural Molecules and Innovative Drugs, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
Jiayi Li *School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, 529020, China.
Yuhan XiaoSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen, 529020, China.
Huiling XuSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen, 529020, China.
Junqiu ZhangCenter for Bioactive Natural Molecules and Innovative Drugs, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
Min-Jing ChengCenter for Bioactive Natural Molecules and Innovative Drugs, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China. chengmj1235@jnu.edu.cn.
Junyang LiuSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen, 529020, China. liujy@wyu.edu.cn.
Jia-Lei YanSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen, 529020, China. yanjialei@wyu.edu.cn.ORCID https://orcid.org/0000-0003-3804-9507

Funding

Guangdong Basic and Applied Basic Research Foundation 2023A1515012715Jiangmen Basic and Applied Basic Research Project 202301003003140State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University SKLBMDA-2025116
6 · The paper itself

Abstract

Menominin A is a natural cyclodepsipeptide isolated from the freshwater sponge-associated cyanobacterium Nostoc sp. UIC 10,607, and exhibits antiproliferative activity against the high-grade serous ovarian cancer cell line OVCAR3. The pronounced biological relevance and limited natural abundance have rendered menominin A a compelling target for total synthesis and biological studies. Herein, we report the total synthesis and cytotoxicity evaluation of the proposed structure of menominin A and its seven isomers. Key features of this synthesis include an Evans aldol reaction to construct the 3-hydroxy-2-methylcarboxylic acid unit, a chiral phosphonic acid-mediated asymmetric allylic addition to establish a chiral alcohol, and a ring-closing metathesis followed by hydrogenation to construct the macrocyclic framework. The mismatch between the NMR spectra of our synthetic samples and those of the natural product suggests that the originally proposed structure is incorrect. Biological evaluation indicated that three compounds (1a, 1b, and 1g) displayed moderate to potent antitumor activity against osteosarcoma, human colon cancer, and prostate cancer. The most active compound 1a exhibited antiproliferative activity against RM-1 cells in a sustained manner, yielding IC

Indexed as

Antitumor activityCyclodepsipeptideMenominin ATotal synthesis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.